Russia is working on a new drug “Biogem” against COVID-19. The drug is based on blood plasma undergoing coronavirus infection. He has already passed the first phase of clinical trials. Production of a solution of immunoglobulin will deal with rostec, the Russian direct investment Fund. This is stated on the website of the company RDIF. After check drug rostec is ready to start its production at four sites in the country in Perm, Nizhny Novgorod, Tomsk and Ufa. In turn, CEO of RDIF, Kirill Dmitriev, called the production of drugs based on blood plasma donors recovered coronavirus, one of the promising directions of treatment.
© 2020, paradox. All rights reserved.